Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial.
Rech J, Taşçilar K, Hagen M, Kleyer A, Manger B, Schoenau V, Hueber A, Kleinert S, Baraliakos X, Braun J, Kiltz U, Fleck M, Rubbert-Roth A, Kofler D, Behrens F, Feuchtenberger M, Zaenker M, Voll R, Venhoff N, Thiel J, Glaser C, Feist E, Burmester G, Karberg K, Strunk J, Cañete J, Senolt L, Filkova M, Naredo E, Largo R, Krönke G, D'Agostino M, Østergaard M, Schett G. Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial. Lancet 2024; 403:850-859.
Feb 13, 2024
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial.
Feb 13, 2024
Lancet 2024; 403:850-859
Rech Juergen, Taşçilar Koray, Hagen Melanie, Kleyer Arnd, Manger Bernhard, Schoenau Verena, Hueber Axel J, Kleinert Stefan, Baraliakos Xenofon, Braun Jürgen, Kiltz Uta, Fleck Martin, Rubbert-Roth Andrea, Kofler David M, Behrens Frank, Feuchtenberger Martin, Zaenker Michael, Voll Reinhard E, Venhoff Nils, Thiel Jens, Glaser Cornelia, Feist Eugen, Burmester Gerd R, Karberg Kirsten, Strunk Johannes, Cañete Juan D, Senolt Ladislav, Filkova Maria, Naredo Esperanza, Largo Raquel, Krönke Gerhard, D'Agostino Maria-Antonietta, Østergaard Mikkel, Schett Georg
more
